TFIIF RAP 30 Activators encompass a spectrum of chemical compounds that indirectly promote the functional activity of TFIIF RAP 30 through intricate signaling pathways, which are essential for the regulation of transcription initiation. Forskolin, with its ability to activate adenylate cyclase, and Rolipram, an inhibitor of phosphodiesterase 4, both elevate intracellular cAMP levels, subsequently activating protein kinase A (PKA). This activation potentially leads to the phosphorylation of transcription components that interact with TFIIF RAP 30, which is instrumental in forming the transcription preinitiation complex. In a parallel manner, Ionomycin raises intracellular calcium levels, triggering calmodulin and calcium/calmodulin-dependent protein kinases, which might modify transcription factors and coactivators, thereby enhancing the function of TFIIF RAP 30. Caffeine and IBMX, both phosphodiesterase inhibitors, contribute similarly to this process by increasing cAMP levels, fostering a favorable environment for TFIIF RAP 30 activity through PKA-dependent phosphorylation.
Other compounds such as PMA and BIM-I manipulate the phosphorylation state of the transcriptional machinery through their respective activation and inhibition of PKC, implying a nuanced layer of control over TFIIF RAP 30 activity. Okadaic Acid, Calyculin A, and Cantharidin, all protein phosphatase inhibitors, maintain a higher phosphorylation state within the transcription machinery, which could stabilize the preinitiation complex and, as a result, amplify TFIIF RAP 30's activity. Moreover, Epigallocatechin-3-Gallate (EGCG) inhibits various protein kinases, potentially altering the interaction and function of transcription factors with TFIIF RAP 30. Lastly, Sanguinarine, by inhibiting NF-κB, may result in the modulation of transcription factor activity that synergizes with TFIIF RAP 30, further promoting its role in transcription initiation. Collectively, these activators function through distinct but interconnected pathways, culminating in the enhanced activity of TFIIF RAP 30, a key player in the transcription initiation complex.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing the intracellular levels of cAMP. Elevated cAMP activates PKA, which can phosphorylate transcription factors and coactivators involved in the initiation complex with TFIIF RAP 30. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can phosphorylate proteins involved in transcription regulation, potentially enhancing the activity of TFIIF RAP 30 by promoting assembly of the preinitiation complex. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium, which activates calmodulin and calcium/calmodulin-dependent protein kinases. These kinases could modify factors interacting with TFIIF RAP 30, thus enhancing its function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to increased cAMP levels which may enhance TFIIF RAP 30 activity by similar mechanisms as Forskolin, via PKA-dependent phosphorylation processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, increasing cAMP levels, which may lead to PKA activation and subsequent phosphorylation of transcription components that work with TFIIF RAP 30. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
BIM-I is a PKC inhibitor that, through inhibition of PKC, might result in altered phosphorylation states of transcriptional machinery, indirectly enhancing the activity of TFIIF RAP 30. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases 1 and 2A, which could lead to increased phosphorylation of transcription factors and potentially enhance the activity of TFIIF RAP 30 by stabilizing the initiation complex. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine inhibits phosphodiesterases, raising cAMP levels, potentially enhancing TFIIF RAP 30 activity through PKA-mediated phosphorylation of transcriptional machinery. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases, particularly PP1 and PP2A, leading to increased phosphorylation of transcription factors and potentially enhancing TFIIF RAP 30 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases, potentially altering the phosphorylation state of transcription factors and coactivators that interact with TFIIF RAP 30, enhancing its activity in the transcription initiation complex. | ||||||